AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 282 filers reported holding AMEDISYS INC in Q3 2023. The put-call ratio across all filers is 10.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380,698 | +5.4% | 4,076 | +3.2% | 0.01% | 0.0% |
| Q2 2023 | $361,279 | +14.2% | 3,951 | -8.1% | 0.01% | 0.0% |
| Q1 2023 | $316,265 | -11.1% | 4,300 | +1.0% | 0.01% | -16.7% |
| Q4 2022 | $355,630 | -3.6% | 4,257 | +11.8% | 0.01% | -14.3% |
| Q3 2022 | $369,000 | -9.6% | 3,809 | -1.8% | 0.01% | -12.5% |
| Q2 2022 | $408,000 | -63.4% | 3,877 | -40.1% | 0.01% | -57.9% |
| Q1 2022 | $1,115,000 | +6.1% | 6,470 | -0.4% | 0.02% | +18.8% |
| Q4 2021 | $1,051,000 | +7.1% | 6,495 | -1.3% | 0.02% | -15.8% |
| Q3 2021 | $981,000 | -40.0% | 6,581 | -1.4% | 0.02% | -36.7% |
| Q2 2021 | $1,635,000 | -8.5% | 6,676 | -1.1% | 0.03% | -21.1% |
| Q1 2021 | $1,787,000 | -9.7% | 6,747 | 0.0% | 0.04% | -11.6% |
| Q4 2020 | $1,979,000 | +24.6% | 6,747 | +0.5% | 0.04% | +10.3% |
| Q3 2020 | $1,588,000 | +29.4% | 6,715 | +8.7% | 0.04% | +21.9% |
| Q2 2020 | $1,227,000 | – | 6,178 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
| Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
| Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
| RK Capital | 54,900 | $9,459,000 | 1.86% |
| Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
| Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
| Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
| Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
| Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
| Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |